Gen9, Inc. Information

Gen9 is the premier next-generation gene synthesis company focused on high-quality, high-throughput, automated production of DNA constructs. The Gen9 technology allows for the lowest-cost and highest-quality DNA constructs commercially available. Founded by world leaders in synthetic biology, Gen9 aims to ensure the constructive application of synthetic biology in industries ranging from enzyme and chemical production to pharmaceuticals and biofuels. Gen9 is powering the synthetic biology revolution from our headquarters in Cambridge, Massachusetts.

Website	http://gen9bio.com/
Revenue	$8 million
Funding	$50.4 million
Employees	5 (1 on RocketReach)
Founded	2009
Address	Technology Center 840 Memorial Riverside Dr Fl 5, Cambridge, Massachusetts 02139, US
Phone	+1 617-250-8433
Technologies	JavaScript , HTML , PHP +31 more (view full list)
Industry	Biotechnology, Business Services General, Gene Synthesis, Business Services, Science and Engineering, DNA Synthesis, Genetics, Variant Gene Libraries, Health Care, Synthetic Biology, Manufacturing
Keywords	Gene Synthesis, Dna Synthesis, Synthetic Biology, Biotechnology, Molecular Biology, Oligonucleotide Synthesis, Genetic Engineering, Biomanufacturing, Genome Engineering, Genomics, Gene Sequencing, Next Generation Sequencing, Molecular Cloning, Protein Engineering, Drug Discovery
Competitors	Novartis, Amgen, Regeneron, Twist Bioscience, Codexis, Inc., Syndax Pharmaceuticals, Geno, Zymergen, Inc., Arzeda, Molecular Assemblies, Inc. +37 more (view full list)
SIC	SIC Code 873 Companies, SIC Code 87 Companies
NAICS	NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies